New Medicines Australia code ‘flawed’

Professors Jon Jureidini, Alastair MacLennan, Marcello Costa and Associate Professor Ken Harvey are among those who argue that the proposed changes are not strong enough.

The draft 18th code requires pharmaceutical companies to report all consultation fees and expenses paid to individual doctors for educational purposes and advisory board member services but doctors can opt out of being identified.

“It is my view that the ACCC should not provide a fig-leaf of respectability to edition 18 of the Medicines Australia code by authorising the flawed outcome achieved,

Latest

Trending